atorvastatin xiromed 80 mg
medical valley invest ab - atorvastatinkalsiumtrihydrat - tablett, filmdrasjert - 80 mg
sporanox 100 mg
janssen-cilag as - itrakonazol - kapsel, hard - 100 mg
erleada
janssen-cilag international nv - apalutamide - prostata neoplasmer - endokrin terapi - erleada er angitt:i voksne menn for behandling av metastatisk ikke kastrering motstandsdyktig mot prostatakreft (nmcrpc) som har høy risiko for å utvikle metastatisk sykdom. i voksne menn for behandling av metastatisk hormone-sensitive prostatakreft (mhspc) i kombinasjon med androgen mangel terapi (adt).
talzenna
pfizer europe ma eeig - talazoparib - bryst neoplasms - antineoplastiske midler - talzenna er indisert som monoterapi for behandling av voksne pasienter med germline brca1/2 mutasjoner, som har her2-negative lokalt avansert eller metastatisk brystkreft. patients should have been previously treated with an anthracycline and/or a taxane in the (neo)adjuvant, locally advanced or metastatic setting unless patients were not suitable for these treatments. pasienter med hormon-reseptor (hr)-positiv brystkreft burde ha blitt behandlet med en tidligere endokrine-basert terapi, eller anses som uegnet for endokrin-basert terapi.
atorvastatin krka 80 mg
krka sverige ab - atorvastatinkalsium - tablett, filmdrasjert - 80 mg
ritonavir accord 100 mg
accord healthcare b.v. - ritonavir - tablett, filmdrasjert - 100 mg
copiktra
secura bio limited - duvelisib - leukemia, lymphocytic, chronic, b-cell; lymphoma, follicular - antineoplastiske midler - copiktra monotherapy is indicated for the treatment of adult patients with: relapsed or refractory chronic lymphocytic leukaemia (cll) after at least two prior therapies. follicular lymphoma (fl) that is refractory to at least two prior systemic therapies.
tukysa
seagen b.v. - tucatinib - breast neoplasms; neoplasm metastasis - antineoplastiske midler - tukysa is indicated in combination with trastuzumab and capecitabine for the treatment of adult patients with her2‑positive locally advanced or metastatic breast cancer who have received at least 2 prior anti‑her2 treatment regimens.
atorvastatin accord 10 mg
accord healthcare b.v. - atorvastatinkalsiumtrihydrat - tablett, filmdrasjert - 10 mg
atorvastatin accord 20 mg
accord healthcare b.v. - atorvastatinkalsiumtrihydrat - tablett, filmdrasjert - 20 mg